John Kim - Access Bio Managing Partner
| 950130 Stock | KRW 5,530 190.00 3.56% |
Insider
John Kim is Managing Partner of Access Bio
| Phone | 732 873 4040 |
| Web | http://www.accessbiodiagnostics.net |
John Kim Latest Insider Activity
Tracking and analyzing the buying and selling activities of John Kim against Access Bio stock is an integral part of due diligence when investing in Access Bio. John Kim insider activity provides valuable insight into whether Access Bio is net buyers or sellers over its current business cycle. Note, Access Bio insiders must abide by specific rules, including filing SEC forms every time they buy or sell Access Bio'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
John Kim over six months ago Disposition of 882 shares by John Kim of Cognizant Technology subject to Rule 16b-3 |
Access Bio Management Efficiency
The company has return on total asset (ROA) of 0.3467 % which means that it generated a profit of $0.3467 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 108.0209 %, meaning that it generated $108.0209 on every $100 dollars invested by stockholders. Access Bio's management efficiency ratios could be used to measure how well Access Bio manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 9 records | INSIDER Age | ||
| Lee Koo | UNISEM Co | 61 | |
| Yin Cho | Humasis Co | 53 | |
| Seok Lee | Humasis Co | 45 | |
| Seong Yim | Humasis Co | 44 | |
| Kim Kyoon | UNISEM Co | 64 | |
| Jeong Kim | Humasis Co | 45 | |
| Cho Bum | UNISEM Co | 61 | |
| Gwang Cho | Humasis Co | 53 | |
| Hyeong Kim | Humasis Co | 39 | |
Management Performance
| Return On Equity | 108.02 | |||
| Return On Asset | 0.35 |
Access Bio Leadership Team
Elected by the shareholders, the Access Bio's board of directors comprises two types of representatives: Access Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Access. The board's role is to monitor Access Bio's management team and ensure that shareholders' interests are well served. Access Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Access Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andrew Gorman, B Board | ||
| Terry Kim, Chief Africa | ||
| Philip CPA, Treasurer Board | ||
| John Kim, Managing Partner | ||
| N MD, Clinical Board | ||
| YoungHo Choi, CEO Pres | ||
| Janet Strong, DODG Board |
Access Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Access Bio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 108.02 | |||
| Return On Asset | 0.35 | |||
| Profit Margin | 0.40 % | |||
| Operating Margin | 0.55 % | |||
| Current Valuation | 1.03 T | |||
| Shares Outstanding | 26.79 M | |||
| Shares Owned By Insiders | 25.25 % | |||
| Shares Owned By Institutions | 0.08 % | |||
| Price To Earning | 149.71 X | |||
| Price To Sales | 1.44 X |
Pair Trading with Access Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Access Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Access Bio will appreciate offsetting losses from the drop in the long position's value.Moving together with Access Stock
Moving against Access Stock
The ability to find closely correlated positions to Access Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Access Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Access Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Access Bio to buy it.
The correlation of Access Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Access Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Access Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Access Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Access Stock
Access Bio financial ratios help investors to determine whether Access Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Access with respect to the benefits of owning Access Bio security.